Brief: Lidds: Liproca Depot Open Label Extension Study Indicates Longer Treatment Intervals

Lidds AB

06/05/2019 07:56

May 6 (Reuters) - Lidds AB  LIDDS.ST :
    * REG-LIDDS: LIPROCA® DEPOT OPEN LABEL EXTENSION STUDY
INDICATES
LONGER TREATMENT INTERVALS
    * PRELIMINARY STUDY RESULTS WILL BE AVAILABLE DURING Q3 OF
THIS
YEAR.
    * PRELIMINARY DATA FROM A VOLUNTARY OLE STUDY INDICATES TIME
TO
RE-TREATMENT WITH LIPROCA DEPOT IN PROSTATE CANCER PATIENTS IS
POTENTIALLY LONGER THAN ANTICIPATED.
    * GLOBAL DRUG MARKET FOR PROSTATE CANCER IS EXPECTED TO GROW
TO
MORE THAN USD 8 BILLION BY 2022

Source text for Eikon:  ID:nGNE5Cfjy8 
Further company coverage:  LIDDS.ST 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 587720920;))